A Study Of Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation

StatusRecruiting
PhasePhase 2/3
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Jan 15, 2027 → Jan 2028
See other at-risk trials from Mayo Clinic

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jan 15, 2027 to Jan 2028 Show 4 more changesShow less
    • Start date: Apr 15, 2026 to Jun 4, 2026
    • Study completion pushed from May 31, 2027 to Jul 2028
    • Eligibility criteria expanded, about 22 words
    • Publications: details revised at 1 of 1 entry
  2. Publications expanded, about 44 wordsv3
  3. Recruitment opened
    • Site details revised
    v2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,024 trials monitored
See 128 trials at risk
The purpose of this study is to provide preliminary evidence for the efficacy of 12 weeks of vagal nerve stimulation (VNS) and nicotine replacement therapy (NRT) for increasing smoking abstinence rates.
Trial Details
NCT Number NCT07487818
Lead Sponsor Mayo Clinic
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Smoking Cessation
Related terms Smoking, Smoking Cessation, Tobacco Use Disorder
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov